Wednesday, 6 July 2016

LIST OF ADR MONITORING CENTRES UNDER PHARMACOVIGILANCE PROGRAMME OF INDIA (PVPI)

S.No.
Address
Coordinators
Email Address
1
Indian Pharmacopoeia Commission, Ghaziabad
Dr. G.N. Singh,
Secretary-cum-Scientific Director
National Coordinator
pvpi@ipcindia.net  
ADR Monit0oring Centres (AMC)

  1.  
Department of Pharmacology,
 All India Institute of Medical Sciences, New Delhi.
Dr. Y.K. Gupta
yk.ykgupta@gmail.com

  1.  
Department of Pharmacology,  
 Therapeutics & Toxicology,
Govt. Medical College, Bakshi Nagar, Jammu.
Dr. Vishal Tandon
dr_vishaltandon@yahoo.com

  1.  
Department of Pharmacology,
PGIMER, Chandigarh
Dr. Bikash Medhi
drbikashus@yahoo.com

  1.  
Department of Pharmacology,
 R.G. Kar Medical College, Kolkatta
Dr. Anjan Adhikari
adr.rgk.pharma@gmail.com

  1.  
Department of Pharmacology,
Lady Hardinge Medical College, New Delhi
Dr. H.S. Rehan
harmeetrehan@hotmail.com

  1.  
Department of Clinical Pharmacology,
  Seth GS Medical College & KEM Hospital, Parel, Mumbai
Dr. Urmila Thatte
pvpiitakem@gmail.com

  1.  
Department of Clinical & Experimental Pharmacology,
 School of Tropical Medicine, Chittaranjan Avenue, Kolkata
Dr. Santanu Tripathi
stm.pvpi@gmail.com

  1.  
Department of Pharmacology,
JIPMER, Pondicherry
Dr. C Adithan
adithan@yahoo.com

  1.  
Department of Clinical Pharmacy,
JSS Medical College Hospital, Karnataka
Dr. Parthasarathi G
partha18@gmail.com

  1.  
Department of Pharmacology ,
Medical College, Guwahati. Assam
Dr. Mangala Lahkar
dr_mlahkar@rediffmail.com, 

  1.  
Institute of Pharmacology,
 Madras Medical College, Chennai
Dr. R Nandini
pvpi.chennai@gmail.com

  1.  
Department of Pharmacology,
SAIMS Medical College, Indore-Ujjain
Dr. Chhaya goyal
chhayagl@gmail.com

  1.  
Department of Pharmacology,
 GSVM Medical College, Swaroop Nagar, Kanpur, U.P.
Dr SP Singh
singhdrsp@gmail.com

  1.  
Department of Pharmacology,
Pandit Bhagwat Dayal Sharma, Post Graduate Institute of Medical Sciences,
Rohtak, Haryana.
Dr MC Gupta
dr_mcgupta@yahoo.co.in,
dr.mcgupta57@gmail.com

  1.  
Department of Pharmacology,
Dayanand Medical College and Hospital, Ludhiana, Punjab
Dr. Sandeep Kaushal
skaushal1@yahoo.co.in

  1.  
Department of Clinical Pharmacology,
Sher-i-Kashmir Institute of Medical Sciences, Srinagar, J&K. 
Dr. ZA Wafai
drzawafai@gmail.com

  1.  
Himalayan Institute of Medical Sciences, Dehradun, Uttrakhand
Dr. DC Dhasmana
dhasmanadc@gmail.com

  1.  
Department of Pharmacology,
Santosh Medical University, Santosh Nagar, Ghaziabad
Dr VC Chopra
vipen.chopra@gmail.com

  1.  
Department of Pharmacology,
SMS Medical College, Jaipur
Dr. Mukul Mathur
Mathur_mukul@rediffmail.com
coordpvpimsjp@rediffmail.com

  1.  
Department of Clinical Pharmacology, Christian Medical College,Vellore, Tamil Nadu
Dr. Sujith chandy
sjchandy@gmail.com

  1.  
Department of Pharmacology,
VSS Medical College, Burla, Orissa
Prof. Dr. Shrikanta Mohanty
Bhab_bhab@yahoo.com

  1.  
Department of  Pharmacology,
SCB Medical College, Cuttack, Orissa
Prof. Jyotirmoyee Jena
drtruptiswain@yahoo.com
Posted by at No comments:

History of FDA and Drug Administration

The Food and Drug Administration is the oldest comprehensive consumer protection agency in the U. S. federal government. Its origins can be traced back to the appointment of Lewis Caleb Beck in the Patent Office around 1848 to carry out chemical analyses of agricultural products, a function that the newly created Department of Agriculture inherited in 1862. Although it was not known by its present name until 1930, FDA’s modern regulatory functions began with the passage of the 1906 Pure Food and Drugs Act, a law a quarter-century in the making that prohibited interstate commerce in adulterated and misbranded food and drugs. Harvey Washington Wiley, Chief Chemist of the Bureau of Chemistry in the Department of Agriculture, had been the driving force behind this law and headed its enforcement in the early years, providing basic elements of protection that consumers had never known before that time.
A rectangular shape box with a man battling a skelton (left) and on the right same picture but in the form of a stamp.
The U. S. Post Office recognized the 1906 Act as a landmark of the 20th century when it released this stamp, the design of which was based on a 19th century patent medicine trading card.
The FDA and its responsibilities have undergone a metamorphosis since 1906. Similarly, the marketplace itself, the sciences undergirding the products the agency regulates, and the social, cultural, political, and economic changes that have formed the context for these developments, all have witnessed upheavals over the past century. Yet the core public health mission of the agency remains now as it did then. This web site features a variety of portals that offer insight into these changes, from overviews on how consumer protection laws evolved, to case studies that explore and interpret the agency’s work and policies. In addition, the visitor will find links to key related web sites as well as citations to valuable sources to help understand the history of FDA.
Several people gathered around a table examining items
FDA Inspector William Ford is at the center of activity in dealing with the 1937 flooding of the Ohio River and its impact on regulated commodities.

Images from FDA History

The FDA History Office has mounted a series of 200 posters around the headquarters campus in Silver Spring, Maryland, illustrating the evolution of FDA's work to protect and promote the public health. These include posters from public health campaigns, images of FDA inspectors, analysts, and others at work, and the commodities the agency regulates
Posted by at No comments:

2015-2016 Influenza Season: Availability of Antivirals

  • Tamiflu (oseltamivir phosphate) Oral Suspension
    • No current shortage.
    • If there is difficulty locating commercial Tamiflu for Oral Suspension, FDA would like to remind healthcare professionals of the FDA-approved Instructions for the emergency compounding of an oral suspension from Tamiflu 75 mg capsules. This compounded suspension should not be used for convenience or when the FDA-approved Tamiflu for oral suspension is commercially available.  Please see information for healthcare professionals regarding compounding an oral suspension from Tamiflu 75 mg capsules at: Tamiflu: Emergency Compounding
  • Tamiflu (oseltamivir phosphate) 75 mg Capsules
    • No current shortage.
  • Tamiflu (oseltamivir phosphate) 45 mg Capsules
    • No current shortage.
    • Pediatric patients can be dosed correctly with the 30 mg and 45 mg capsules.
  • Tamiflu (oseltamivir phosphate) 30 mg Capsules
    • No current shortage.
    • Pediatric patients can be dosed correctly with the 30 mg and 45 mg capsules.
  • Relenza (zanamivir) Inhalation Powder
    • No current shortage.
  • Rapivab (peramivir) Injection
    • No current shortage
  • Additional Resources
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)